Northland Securities Maintains a Buy Rating on Strata Skin Sciences Inc (SSKN)

By Jason Carr

Northland Securities analyst Suraj Kalia maintained a Buy rating on Strata Skin Sciences Inc (SSKNResearch Report) today and set a price target of $7. The company’s shares opened today at $2.45.

Kalia wrote:

“We note that fully audited results for Q4-18 and Q1-19 are not available, and there seems to be a delay in the filing of docs, due primarily to some discrepancies related to historical contingent and potential liabilities relates to state sales and use taxes, and some non-cash derivative acctg treatment for debentures issued in 2015. Hence, our models still do not reflect the actuals for the reasons cited above.”

According to TipRanks.com, Kalia is a 5-star analyst with an average return of 10.8% and a 59.0% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Obalon Therapeutics Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Strata Skin Sciences Inc with a $7 average price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $3.88 and a one-year low of $1.42. Currently, Strata Skin Sciences Inc has an average volume of 58.7K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

STRATA Skin Sciences, Inc. is a medical technology company, which engages in the design, development, and commercializing of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.